Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	HIPK3 HDAC9 ATN1 MAP1A BAZ2A MAPT TLE2 FBXO42 SH2D3C TRIM24 THRAP3 CNOT2	2.37e-04	1160	63	12	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	HIPK3 HDAC9 ATN1 MAP1A BAZ2A MAPT TLE2 FBXO42 SH2D3C TRIM24 AHDC1 THRAP3 CNOT2	2.65e-04	1356	63	13	GO:0060090
GeneOntologyCellularComponent	nuclear speck	LIMK1 BAZ2A MAPT YLPM1 DACH1 FOXO4 THRAP3 NXF1	3.91e-05	431	62	8	GO:0016607
GeneOntologyCellularComponent	nuclear body	HIPK3 LIMK1 BAZ2A MAPT TLE2 YLPM1 DACH1 FOXO4 THRAP3 NXF1 ZIC2	6.20e-05	903	62	11	GO:0016604
Domain	RASGEF_CAT	RAPGEF6 SH2D3C RAPGEF2	1.09e-04	29	60	3	PS50009
Domain	RasGEF	RAPGEF6 SH2D3C RAPGEF2	1.20e-04	30	60	3	PF00617
Domain	-	RAPGEF6 SH2D3C RAPGEF2	1.20e-04	30	60	3	1.10.840.10
Domain	Ras_GEF_dom	RAPGEF6 SH2D3C RAPGEF2	1.20e-04	30	60	3	IPR023578
Domain	RASGEF_cat_dom	RAPGEF6 SH2D3C RAPGEF2	1.20e-04	30	60	3	IPR001895
Domain	RasGEF	RAPGEF6 SH2D3C RAPGEF2	1.20e-04	30	60	3	SM00147
Domain	Ser/Thr_kinase_AS	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	9.82e-04	357	60	6	IPR008271
Domain	PROTEIN_KINASE_ST	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	1.05e-03	362	60	6	PS00108
Domain	PDZ	LIMK1 RAPGEF6 RAPGEF2 TIAM2	1.09e-03	141	60	4	PF00595
Domain	PDZ	LIMK1 RAPGEF6 RAPGEF2 TIAM2	1.31e-03	148	60	4	SM00228
Domain	Protein_kinase_ATP_BS	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	1.33e-03	379	60	6	IPR017441
Domain	Pkinase	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	1.37e-03	381	60	6	PF00069
Domain	-	LIMK1 RAPGEF6 RAPGEF2 TIAM2	1.37e-03	150	60	4	2.30.42.10
Domain	PDZ	LIMK1 RAPGEF6 RAPGEF2 TIAM2	1.41e-03	151	60	4	PS50106
Domain	PDZ	LIMK1 RAPGEF6 RAPGEF2 TIAM2	1.44e-03	152	60	4	IPR001478
Domain	-	LIMK1 TRIP6 ZNF185	1.48e-03	70	60	3	2.10.110.10
Domain	Znf_LIM	LIMK1 TRIP6 ZNF185	1.54e-03	71	60	3	IPR001781
Domain	LIM_DOMAIN_1	LIMK1 TRIP6 ZNF185	1.54e-03	71	60	3	PS00478
Domain	LIM_DOMAIN_2	LIMK1 TRIP6 ZNF185	1.54e-03	71	60	3	PS50023
Domain	LIM	LIMK1 TRIP6 ZNF185	1.54e-03	71	60	3	SM00132
Domain	RasGEFN	RAPGEF6 RAPGEF2	1.86e-03	20	60	2	SM00229
Domain	RasGEF_N	RAPGEF6 RAPGEF2	2.05e-03	21	60	2	PF00618
Domain	Ras-like_Gua-exchang_fac_N	RAPGEF6 RAPGEF2	2.25e-03	22	60	2	IPR000651
Domain	RASGEF_NTER	RAPGEF6 RAPGEF2	2.25e-03	22	60	2	PS50212
Domain	Bromodomain_CS	BAZ2A TRIM24	3.14e-03	26	60	2	IPR018359
Domain	AT_hook	BAZ2A AHDC1	3.38e-03	27	60	2	SM00384
Domain	AT_hook_DNA-bd_motif	BAZ2A AHDC1	3.38e-03	27	60	2	IPR017956
Domain	PROTEIN_KINASE_ATP	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	3.48e-03	459	60	6	PS00107
Domain	RA	RAPGEF6 RAPGEF2	4.44e-03	31	60	2	SM00314
Domain	Prot_kinase_dom	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	4.73e-03	489	60	6	IPR000719
Domain	PROTEIN_KINASE_DOM	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	4.92e-03	493	60	6	PS50011
Domain	cNMP	RAPGEF6 RAPGEF2	5.33e-03	34	60	2	SM00100
Domain	cNMP_binding	RAPGEF6 RAPGEF2	5.33e-03	34	60	2	PF00027
Domain	cNMP-bd_dom	RAPGEF6 RAPGEF2	5.64e-03	35	60	2	IPR000595
Domain	CNMP_BINDING_3	RAPGEF6 RAPGEF2	5.64e-03	35	60	2	PS50042
Domain	S_TKc	HIPK3 KALRN WEE1 CDK14 MAP3K6	5.87e-03	359	60	5	SM00220
Domain	RA	RAPGEF6 RAPGEF2	5.96e-03	36	60	2	PF00788
Domain	BROMODOMAIN_1	BAZ2A TRIM24	6.29e-03	37	60	2	PS00633
Domain	RA	RAPGEF6 RAPGEF2	6.29e-03	37	60	2	PS50200
Domain	cNMP-bd-like	RAPGEF6 RAPGEF2	6.62e-03	38	60	2	IPR018490
Domain	Bromodomain	BAZ2A TRIM24	6.62e-03	38	60	2	PF00439
Domain	RA_dom	RAPGEF6 RAPGEF2	7.32e-03	40	60	2	IPR000159
Domain	BROMODOMAIN_2	BAZ2A TRIM24	7.68e-03	41	60	2	PS50014
Domain	Kinase-like_dom	HIPK3 LIMK1 KALRN WEE1 CDK14 MAP3K6	7.73e-03	542	60	6	IPR011009
Domain	BROMO	BAZ2A TRIM24	8.05e-03	42	60	2	SM00297
Domain	Bromodomain	BAZ2A TRIM24	8.05e-03	42	60	2	IPR001487
Domain	-	BAZ2A TRIM24	8.05e-03	42	60	2	1.20.920.10
Domain	TF_fork_head_CS_2	FOXD2 FOXO4	9.59e-03	46	60	2	IPR030456
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CCP110 LIMK1 RAPGEF6 TRIP6 MAPT WEE1 KIAA0232 KIAA1217 COBLL1 CAMSAP3 NAV1 CC2D1A FOXO4 RAPGEF2 CDK14 MAP3K6	2.15e-12	861	63	16	36931259
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	POM121 ATN1 TRIP6 YLPM1 TNRC6B QSER1 TRIM24 AHDC1 CNOT2 NXF1 PRRC2B	5.96e-10	457	63	11	32344865
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIPK3 TNRC18 MAPT KIAA0232 KIAA1217 FBXO42 CAMSAP3 RBM5 NAV1 TNRC6B QSER1 RAPGEF2 CDK14 AHDC1 THRAP3	4.88e-08	1489	63	15	28611215
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RAPGEF6 TRIP6 BAZ2A YLPM1 DACH1 TNRC6B CC2D1A QSER1 THRAP3 PRRC2B	5.35e-08	549	63	10	38280479
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MAP1A TRIP6 MAPT ANXA1 YLPM1 TNRC6B POLR1B CC2D1A THRAP3 NXF1 PRRC2B	6.80e-08	724	63	11	36232890
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TNRC18 MAGEL2 RAPGEF6 POM121 ATN1 MAP1A TRIP6 WEE1 YLPM1	8.15e-08	430	63	9	35044719
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KALRN KIAA1217 NCAN YLPM1 CAMSAP3 NAV1 TNRC6B QSER1 RAPGEF2 THRAP3 PRRC2B ZIC2	1.38e-07	963	63	12	28671696
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TNRC18 ATN1 YLPM1 QSER1 TRIM24 AHDC1 PRRC2B	5.71e-07	268	63	7	33640491
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	GPALPP1 TNRC18 ANXA1 DACH1 RBM5 CC2D1A QSER1 TRIM24 AHDC1 THRAP3 NXF1 PRRC2B	5.86e-07	1103	63	12	34189442
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TNRC18 MAP1A KALRN MAPT ANXA1 KIAA1217 CAMSAP3 NAV1 TNRC6B NACAD THRAP3 CNOT2	8.21e-07	1139	63	12	36417873
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CCP110 MAP1A TRIP6 WEE1 KIAA1217 FBXO42 NAV1 NXF1 PRRC2B	1.12e-06	588	63	9	38580884
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAP1A KALRN MAPT ANXA1 KIAA1217 NCAN ZNF185 CAMSAP3 NAV1 OGDHL RAPGEF2 THRAP3 PRRC2B	1.41e-06	1431	63	13	37142655
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	GPALPP1 KALRN ANXA1 CAMSAP3 TNRC6B PLG RAPGEF2 PRRC2B	2.29e-06	475	63	8	31040226
Pubmed	A human MAP kinase interactome.	HIPK3 HDAC9 POM121 MAP1A KIAA0232 COBLL1 NAV1 RAPGEF2	2.71e-06	486	63	8	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GPALPP1 HDAC9 CCP110 TNRC18 POM121 COBLL1 FBXO42 POM121B	3.01e-06	493	63	8	15368895
Pubmed	The PDZ domain of the guanine nucleotide exchange factor PDZGEF directs binding to phosphatidic acid during brush border formation.	RAPGEF6 RAPGEF2	3.23e-06	2	63	2	24858808
Pubmed	Phosphatidic acid-dependent localization and basal de-phosphorylation of RA-GEFs regulate lymphocyte trafficking.	RAPGEF6 RAPGEF2	3.23e-06	2	63	2	32600317
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	WEE1 RBM5 NAV1 RAPGEF2 THRAP3 ZIC2	4.08e-06	232	63	6	25515538
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ATN1 MAP1A TRIP6 BAZ2A MAPT WEE1 TNRC6B RAPGEF2 TRIM24 PRRC2B ZIC2	4.72e-06	1116	63	11	31753913
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	RAPGEF6 TRIP6 CAMSAP3 RBM5 TNRC6B RAPGEF2 AHDC1	5.56e-06	378	63	7	34315543
Pubmed	Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1.	ANXA1 PLG	9.68e-06	3	63	2	28320709
Pubmed	POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation.	POM121 POM121B	9.68e-06	3	63	2	30802453
Pubmed	Comprehensive behavioral analysis of mice deficient in Rapgef2 and Rapgef6, a subfamily of guanine nucleotide exchange factors for Rap small GTPases possessing the Ras/Rap-associating domain.	RAPGEF6 RAPGEF2	9.68e-06	3	63	2	29747665
Pubmed	Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine.	POM121 POM121B	9.68e-06	3	63	2	35507432
Pubmed	Regulation of vascular endothelial growth factor-induced endothelial cell migration by LIM kinase 1-mediated phosphorylation of annexin 1.	LIMK1 ANXA1	9.68e-06	3	63	2	20061392
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	POM121 ATN1 TRIP6 KALRN TNRC6B AHDC1 NXF1 PRRC2B	1.39e-05	608	63	8	16713569
Pubmed	The DNA sequence of human chromosome 7.	HDAC9 LIMK1 TNRC18 POM121 CDK14 POM121B NACAD	1.51e-05	441	63	7	12853948
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAP1A ANXA1 ZNF185 DACH1 TNRC6B TRIM24 AHDC1	1.57e-05	444	63	7	34795231
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	GPALPP1 CCP110 RAPGEF6 TRIP6 WEE1 KIAA1217 CC2D1A RAPGEF2 THRAP3 CNOT2	1.64e-05	1038	63	10	26673895
Pubmed	Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes.	POM121 POM121B	1.93e-05	4	63	2	17900573
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A TRIP6 NAV1 TNRC6B TRIM24	2.15e-05	184	63	5	32908313
Pubmed	Fine-scale comparative mapping of the human 7q11.23 region and the orthologous region on mouse chromosome 5G: the low-copy repeats that flank the Williams-Beuren syndrome deletion arose at breakpoint sites of an evolutionary inversion(s).	LIMK1 POM121 POM121B	3.56e-05	35	63	3	11013070
Pubmed	The protein interaction landscape of the human CMGC kinase group.	HIPK3 CCP110 LIMK1 KIAA0232 NAV1 CDK14 THRAP3 CNOT2	3.59e-05	695	63	8	23602568
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CCP110 RAPGEF6 MAP1A FBXO42 TNRC6B	3.96e-05	209	63	5	36779422
Pubmed	Interaction network of human early embryonic transcription factors.	TNRC18 ATN1 QSER1 TRIM24 AHDC1 PRRC2B	4.24e-05	351	63	6	38297188
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPALPP1 RAPGEF6 MAP1A BAZ2A KIAA1217 YLPM1 TNRC6B CC2D1A PRRC2B	4.51e-05	934	63	9	33916271
Pubmed	Generation and comparative analysis of approximately 3.3 Mb of mouse genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in Williams syndrome.	LIMK1 POM121 POM121B	4.57e-05	38	63	3	11779826
Pubmed	Human transcription factor protein interaction networks.	ATN1 TRIP6 YLPM1 DACH1 TNRC6B CC2D1A QSER1 TRIM24 CNOT2 NXF1 PRRC2B	4.68e-05	1429	63	11	35140242
Pubmed	The transition from meiotic to mitotic spindle assembly is gradual during early mammalian development.	CCP110 KIF12	4.82e-05	6	63	2	22851319
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	ATN1 ANXA1 YLPM1 RAPGEF2 THRAP3	5.05e-05	220	63	5	24550385
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	MAP1A ANXA1 KIAA1217 ZNF185 YLPM1 RBM5 AHDC1 PRRC2B	5.17e-05	732	63	8	34732716
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	CCP110 YLPM1 RBM5 NAV1 TNRC6B POLR1B QSER1 CNOT2	5.22e-05	733	63	8	34672954
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	WEE1 QSER1 TRIM24 PRRC2B	6.01e-05	116	63	4	30804394
Pubmed	Tau knockout exacerbates degeneration of parvalbumin-positive neurons in substantia nigra pars reticulata in Parkinson's disease-related α-synuclein A53T mice.	MAP1A MAPT	6.74e-05	7	63	2	33000527
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPGEF6 ATN1 BAZ2A MAPT WEE1 YLPM1 CAMSAP3 THRAP3	7.63e-05	774	63	8	15302935
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	TNRC6B POLR1B QSER1 NXF1 PRRC2B	7.92e-05	242	63	5	34011540
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	GPALPP1 POM121 TRIP6 MAPT TNRC6B CC2D1A CNOT2 NXF1 PRRC2B	8.03e-05	1007	63	9	34597346
Pubmed	PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.	RAPGEF6 TRIP6 YLPM1 TNRC6B THRAP3	8.72e-05	247	63	5	32989298
Pubmed	TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation.	THRAP3 NXF1	8.98e-05	8	63	2	20123736
Pubmed	Perinatal lethality of microtubule-associated protein 1B-deficient mice expressing alternative isoforms of the protein at low levels.	MAP1A MAPT	8.98e-05	8	63	2	11085878
Pubmed	Defects in Synaptic Plasticity, Reduced NMDA-Receptor Transport, and Instability of Postsynaptic Density Proteins in Mice Lacking Microtubule-Associated Protein 1A.	MAP1A MAPT	8.98e-05	8	63	2	26609151
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAPGEF6 CAMSAP3 NAV1 TNRC6B TRIM24 NXF1	1.11e-04	418	63	6	34709266
Pubmed	Efficient conditional and promoter-specific in vivo expression of cDNAs of choice by taking advantage of recombinase-mediated cassette exchange using FlEx gene traps.	KIAA1217 AHDC1	1.15e-04	9	63	2	20139417
Pubmed	Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression.	MAP1A MAPT	1.15e-04	9	63	2	28424350
Pubmed	TRIM46 Controls Neuronal Polarity and Axon Specification by Driving the Formation of Parallel Microtubule Arrays.	MAPT NAV1	1.15e-04	9	63	2	26671463
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	POM121 TRIP6 KIAA1217 TNRC6B PRRC2B	1.17e-04	263	63	5	34702444
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MAP1A KALRN YLPM1 RBM5 TNRC6B ZC3H6 AHDC1 THRAP3 NXF1	1.38e-04	1082	63	9	38697112
Pubmed	The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control.	THRAP3 NXF1	1.44e-04	10	63	2	18596238
Pubmed	JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function.	RAPGEF6 RAPGEF2	1.44e-04	10	63	2	23885123
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TRIP6 KIAA0232 KIAA1217 ZNF185 CAMSAP3 TNRC6B CC2D1A PRRC2B	1.49e-04	853	63	8	28718761
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	MAP1A KALRN NCAN CAMSAP3 RAPGEF2	1.59e-04	281	63	5	28706196
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TNRC18 RAPGEF6 KALRN NAV1 OGDHL CC2D1A AHDC1 TIAM2 PRRC2B	1.62e-04	1105	63	9	35748872
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	BAZ2A ANXA1 YLPM1 DACH1 THRAP3	1.65e-04	283	63	5	30585729
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ATN1 ZNF185 TNRC6B PRRC2B	1.71e-04	152	63	4	38360978
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RAPGEF6 ATN1 CAMSAP3 QSER1 MAP3K6 NXF1 PRRC2B	1.72e-04	650	63	7	38777146
Pubmed	MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration.	HDAC9 MAPT	1.76e-04	11	63	2	31223056
Pubmed	Role of Pax6 in development of the cerebellar system.	MAPT ZIC2	1.76e-04	11	63	2	10409504
Pubmed	Nuclear export factor family protein participates in cytoplasmic mRNA trafficking.	MAP1A NXF1	1.76e-04	11	63	2	16014633
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	HDAC9 HOXD1 TLE2 DACH1 POLR1B TRIM24 CNOT2 ZIC2	1.80e-04	877	63	8	20211142
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TNRC18 TRIP6 YLPM1 CAMSAP3 TNRC6B THRAP3 PRRC2B	1.81e-04	655	63	7	35819319
Pubmed	CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity.	MAPT CAMSAP3	2.11e-04	12	63	2	32839317
Pubmed	Crucial Role of Rapgef2 and Rapgef6, a Family of Guanine Nucleotide Exchange Factors for Rap1 Small GTPase, in Formation of Apical Surface Adherens Junctions and Neural Progenitor Development in the Mouse Cerebral Cortex.	RAPGEF6 RAPGEF2	2.49e-04	13	63	2	27390776
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CCP110 KALRN COBLL1 CAMSAP3 CC2D1A THRAP3	3.00e-04	503	63	6	16964243
Pubmed	Rap2A links intestinal cell polarity to brush border formation.	RAPGEF6 RAPGEF2	3.34e-04	15	63	2	22797597
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	POM121 POM121B	3.34e-04	15	63	2	14697343
Pubmed	GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets.	TNRC6B CNOT2	3.34e-04	15	63	2	21981923
Pubmed	Role of TIF1alpha as a modulator of embryonic transcription in the mouse zygote.	QSER1 TRIM24	3.81e-04	16	63	2	16880268
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	HIPK3 KIAA1217 TNRC6B POLR1B AHDC1 CNOT2	4.29e-04	538	63	6	10512203
Pubmed	New gene functions in megakaryopoiesis and platelet formation.	KALRN BAZ2A KIAA0232	4.37e-04	81	63	3	22139419
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	RBM5 MUC16 TNRC6B CC2D1A RAPGEF2 THRAP3 PRRC2B	5.05e-04	777	63	7	35844135
Pubmed	A genomic atlas of mouse hypothalamic development.	MAGEL2 TRIP6 NCAN ZIC2	5.32e-04	205	63	4	20436479
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	TRIP6 ANXA1 KIAA1217 COBLL1 ZNF185 CC2D1A	5.55e-04	565	63	6	25468996
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CCP110 POM121 WEE1 COBLL1 CAMSAP3 NAV1 QSER1 CNOT2 PRRC2B	5.98e-04	1321	63	9	27173435
Pubmed	EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway.	TNRC6B PRRC2B	6.63e-04	21	63	2	33029523
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ANXA1 COBLL1 YLPM1 RBM5 TNRC6B CC2D1A THRAP3 NXF1 PRRC2B	7.79e-04	1371	63	9	36244648
Pubmed	Conserved beta-hairpin recognition by the GYF domains of Smy2 and GIGYF2 in mRNA surveillance and vesicular transport complexes.	ATN1 TNRC6B	7.97e-04	23	63	2	20696395
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP1A MAPT THRAP3 PRRC2B	8.31e-04	231	63	4	16452087
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	BAZ2A KIAA0232 NAV1 TNRC6B PRRC2B	8.62e-04	407	63	5	12693553
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DNHD1 CCP110 COBLL1 THRAP3	8.72e-04	234	63	4	36243803
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KIAA1217 NAV1 OGDHL	8.80e-04	103	63	3	10574462
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FBXO42 DACH1 FOXO4 QSER1 TRIM24 THRAP3 ZIC2	8.98e-04	857	63	7	25609649
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	BAZ2A RAPGEF2 NACAD	9.05e-04	104	63	3	9205841
Pubmed	Intermediate phenotypes identify divergent pathways to Alzheimer's disease.	RGSL1 MAPT	9.43e-04	25	63	2	20574532
Pubmed	Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.	TNRC6B CC2D1A CNOT2	9.83e-04	107	63	3	30995489
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	POM121 WEE1 YLPM1 POLR1B NXF1	1.22e-03	440	63	5	34244565
Pubmed	Roof Plate-Derived Radial Glial-like Cells Support Developmental Growth of Rapidly Adapting Mechanoreceptor Ascending Axons.	MAPT ZIC2	1.27e-03	29	63	2	29874580
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	POM121 ATN1	1.27e-03	29	63	2	17577209
Pubmed	Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors.	HDAC9 BAZ2A	1.27e-03	29	63	2	24105743
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	HIPK3 LIMK1 WEE1 ANXA1 CDK14 MAP3K6 THRAP3	1.27e-03	910	63	7	36736316
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CCP110 RAPGEF6 NAV1 TNRC6B RAPGEF2	1.29e-03	446	63	5	24255178
Interaction	NUP35 interactions	POM121 ATN1 TRIP6 YLPM1 TNRC6B QSER1 TRIM24 AHDC1 CNOT2 NXF1 PRRC2B	7.24e-08	424	63	11	int:NUP35
Interaction	CEP128 interactions	CCP110 TRIP6 MAPT ANXA1 CAMSAP3 NAV1 TNRC6B CC2D1A NXF1	3.42e-07	297	63	9	int:CEP128
Interaction	SMG7 interactions	TLE2 FBXO42 YLPM1 DACH1 RBM5 TNRC6B TRIM24 CNOT2 PRRC2B	6.23e-07	319	63	9	int:SMG7
Interaction	YWHAH interactions	CCP110 RAPGEF6 TRIP6 MAPT WEE1 KIAA0232 KIAA1217 COBLL1 CAMSAP3 NAV1 CC2D1A FOXO4 RAPGEF2 CDK14 MAP3K6	1.09e-06	1102	63	15	int:YWHAH
Interaction	SFN interactions	HDAC9 CCP110 RAPGEF6 MAP1A MAPT WEE1 KIAA0232 COBLL1 CAMSAP3 NAV1 FOXO4 MAP3K6	1.31e-06	692	63	12	int:SFN
Interaction	HELZ interactions	POM121 TLE2 FBXO42 TNRC6B TRIM24 CNOT2 NXF1 PRRC2B	1.33e-06	257	63	8	int:HELZ
Interaction	GSK3A interactions	CCP110 TNRC18 RAPGEF6 MAP1A MAPT FBXO42 TNRC6B ZC3H6 AHDC1 THRAP3	1.63e-06	464	63	10	int:GSK3A
Interaction	YWHAZ interactions	HDAC9 CCP110 LIMK1 RAPGEF6 MAPT WEE1 ANXA1 KIAA0232 COBLL1 SH2D3C CAMSAP3 NAV1 FOXO4 RAPGEF2 CDK14 NXF1	2.02e-06	1319	63	16	int:YWHAZ
Interaction	TRIM36 interactions	CCP110 MAP1A MAPT CAMSAP3 NAV1 CC2D1A	5.83e-06	144	63	6	int:TRIM36
Interaction	GARRE1 interactions	TRIP6 FBXO42 TNRC6B TRIM24 CNOT2 PRRC2B	1.36e-05	167	63	6	int:GARRE1
Interaction	CEP85 interactions	TLE2 FBXO42 TNRC6B CNOT2 NXF1 PRRC2B	1.46e-05	169	63	6	int:CEP85
Interaction	EGR2 interactions	TNRC18 ATN1 QSER1 TRIM24 AHDC1 PRRC2B	1.56e-05	171	63	6	int:EGR2
Interaction	CEP135 interactions	CCP110 TRIP6 CAMSAP3 NAV1 TNRC6B CC2D1A PRRC2B	2.19e-05	272	63	7	int:CEP135
Interaction	SHANK3 interactions	ATN1 MAP1A KALRN MAPT KIAA0232 NCAN RBM5 RAPGEF2 THRAP3	2.24e-05	496	63	9	int:SHANK3
Interaction	YWHAG interactions	CCP110 RAPGEF6 MAPT WEE1 KIAA0232 COBLL1 SH2D3C CAMSAP3 NAV1 FOXO4 RAPGEF2 CDK14 MAP3K6 THRAP3	2.42e-05	1248	63	14	int:YWHAG
Interaction	CEP192 interactions	FBXO42 SH2D3C TNRC6B CNOT2 NXF1 PRRC2B	2.99e-05	192	63	6	int:CEP192
Interaction	SAMD4B interactions	CCP110 NAV1 TNRC6B CNOT2 PRRC2B	3.97e-05	122	63	5	int:SAMD4B
Interaction	MAGEA9 interactions	CCP110 RAPGEF6 CAMSAP3 RAPGEF2 TRIM24 CNOT2	4.68e-05	208	63	6	int:MAGEA9
Interaction	PCM1 interactions	CCP110 MAGEL2 KIAA1217 FBXO42 CAMSAP3 RBM5 NAV1 CC2D1A	5.96e-05	434	63	8	int:PCM1
Interaction	MEX3B interactions	TRIP6 CAMSAP3 TNRC6B CC2D1A CNOT2 PRRC2B	6.72e-05	222	63	6	int:MEX3B
Interaction	SYNE3 interactions	CCP110 TRIP6 KIAA1217 CAMSAP3 NAV1 TNRC6B CC2D1A PRRC2B	6.98e-05	444	63	8	int:SYNE3
Interaction	MAPRE3 interactions	CCP110 MAP1A MAPT KIAA1217 CAMSAP3 NAV1	8.17e-05	230	63	6	int:MAPRE3
Interaction	FBXO38 interactions	WEE1 QSER1 TRIM24 NXF1 PRRC2B	9.04e-05	145	63	5	int:FBXO38
Interaction	EYA4 interactions	ATN1 TRIP6 ZNF185 TNRC6B QSER1 PRRC2B	1.11e-04	243	63	6	int:EYA4
Interaction	YAP1 interactions	TNRC18 RAPGEF6 ATN1 TRIP6 BAZ2A YLPM1 DACH1 TNRC6B CC2D1A RAPGEF2 THRAP3 NXF1	1.27e-04	1095	63	12	int:YAP1
Interaction	GPBP1L1 interactions	FBXO42 TNRC6B CNOT2 NXF1	1.52e-04	86	63	4	int:GPBP1L1
Interaction	NAGK interactions	YLPM1 DACH1 AHDC1 PRRC2B ZIC2	1.52e-04	162	63	5	int:NAGK
Interaction	DCTN1 interactions	MAP1A MAPT ANXA1 KIAA1217 CAMSAP3 NAV1 CC2D1A NXF1	1.52e-04	497	63	8	int:DCTN1
Interaction	PRRC2B interactions	ATN1 FBXO42 TNRC6B CNOT2 NXF1 PRRC2B	1.77e-04	265	63	6	int:PRRC2B
Interaction	VIM interactions	CCP110 ATN1 MAPT WEE1 KIAA1217 CAMSAP3 NAV1 TNRC6B CC2D1A NXF1	1.81e-04	804	63	10	int:VIM
Interaction	TNIK interactions	KALRN MAPT KIAA1217 THRAP3 TIAM2 PRRC2B ZIC2	1.82e-04	381	63	7	int:TNIK
Interaction	EPB41L3 interactions	TNRC18 MAGEL2 KALRN MAPT DACH1 NACAD	2.04e-04	272	63	6	int:EPB41L3
Interaction	CNOT6L interactions	KIAA0232 TNRC6B CNOT2 PRRC2B	2.06e-04	93	63	4	int:CNOT6L
Interaction	AR interactions	HIPK3 TNRC18 ATN1 KIAA1217 YLPM1 SH2D3C QSER1 TRIM24 AHDC1 THRAP3 PRRC2B	2.28e-04	992	63	11	int:AR
Interaction	PPID interactions	GPALPP1 MAPT SH2D3C ZIC2	2.32e-04	96	63	4	int:PPID
Interaction	TNRC6B interactions	MAPT TNRC6B TRIM24 CNOT2 NXF1 PRRC2B	2.48e-04	282	63	6	int:TNRC6B
Interaction	AGO1 interactions	MAPT TNRC6B TRIM24 CNOT2 NXF1	2.68e-04	183	63	5	int:AGO1
Interaction	YWHAB interactions	CCP110 RAPGEF6 MAPT WEE1 KIAA0232 COBLL1 CAMSAP3 NAV1 FOXO4 RAPGEF2 CDK14	2.75e-04	1014	63	11	int:YWHAB
Interaction	DHX8 interactions	GPALPP1 YLPM1 RBM5 POLR1B THRAP3 NXF1	2.99e-04	292	63	6	int:DHX8
Interaction	VASP interactions	CCP110 MAP1A COBLL1 TNRC6B FYB1 NXF1	3.10e-04	294	63	6	int:VASP
Interaction	RBM14 interactions	HDAC9 LIMK1 ATN1 MAPT YLPM1 RBM5 CDK14 THRAP3	3.14e-04	553	63	8	int:RBM14
Interaction	RNF214 interactions	TRIP6 TNRC6B CNOT2 PRRC2B	3.16e-04	104	63	4	int:RNF214
Interaction	KCTD13 interactions	MAP1A KALRN MAPT ANXA1 KIAA1217 NCAN ZNF185 CAMSAP3 NAV1 OGDHL RAPGEF2 THRAP3 PRRC2B	3.16e-04	1394	63	13	int:KCTD13
Interaction	HNF1B interactions	DACH1 QSER1 TRIM24 THRAP3 PRRC2B	3.19e-04	190	63	5	int:HNF1B
Interaction	UBAP2L interactions	MAGEL2 MAPT TNRC6B CNOT2 NXF1 PRRC2B	3.33e-04	298	63	6	int:UBAP2L
Interaction	XRRA1 interactions	KIAA0232 NXF1	3.41e-04	9	63	2	int:XRRA1
Interaction	SOX2 interactions	TNRC18 MAP1A ANXA1 KIAA1217 ZNF185 YLPM1 DACH1 RBM5 QSER1 TRIM24 AHDC1 THRAP3 PRRC2B	3.84e-04	1422	63	13	int:SOX2
Interaction	SYNGAP1 interactions	MAP1A TRIP6 KALRN MAPT NCAN RAPGEF2	3.90e-04	307	63	6	int:SYNGAP1
Interaction	ADAM22 interactions	KALRN MAPT NXF1	4.02e-04	46	63	3	int:ADAM22
Interaction	CECR2 interactions	TRIP6 WEE1 PRRC2B	4.02e-04	46	63	3	int:CECR2
Interaction	CEBPA interactions	GPALPP1 TNRC18 ANXA1 DACH1 RBM5 CC2D1A QSER1 TRIM24 AHDC1 THRAP3 NXF1 PRRC2B	4.15e-04	1245	63	12	int:CEBPA
Interaction	NDC80 interactions	CCP110 KIAA1217 FBXO42 CAMSAP3 NAV1 NXF1	4.25e-04	312	63	6	int:NDC80
Interaction	ATP5F1EP2 interactions	MAPT WEE1	4.26e-04	10	63	2	int:ATP5F1EP2
Interaction	HDAC4 interactions	GPALPP1 HDAC9 KALRN CAMSAP3 NAV1 TNRC6B RAPGEF2 THRAP3 PRRC2B	4.82e-04	744	63	9	int:HDAC4
Interaction	MAP1A interactions	MAP1A MAPT FBXO42 NXF1	4.94e-04	117	63	4	int:MAP1A
Interaction	CAMKV interactions	GPALPP1 TNRC18 MAPT THRAP3	5.10e-04	118	63	4	int:CAMKV
Interaction	RAPGEF4 interactions	MAP1A KALRN RAPGEF2	5.14e-04	50	63	3	int:RAPGEF4
Interaction	NINL interactions	CCP110 ANXA1 KIAA1217 CAMSAP3 TNRC6B CC2D1A PRRC2B	5.52e-04	458	63	7	int:NINL
Interaction	ZC3H7A interactions	FBXO42 TNRC6B CC2D1A CNOT2 PRRC2B	5.61e-04	215	63	5	int:ZC3H7A
Interaction	TFEB interactions	MAPT FBXO42 DACH1	5.77e-04	52	63	3	int:TFEB
Interaction	PXN interactions	CCP110 LIMK1 TRIP6 KIAA1217 TNRC6B NXF1	6.08e-04	334	63	6	int:PXN
Interaction	YWHAQ interactions	CCP110 RAPGEF6 MAPT WEE1 ANXA1 COBLL1 CAMSAP3 NAV1 PLG RAPGEF2 CDK14	6.29e-04	1118	63	11	int:YWHAQ
Interaction	CTNND2 interactions	ATN1 KALRN MAPT	6.45e-04	54	63	3	int:CTNND2
Interaction	BTRC interactions	WEE1 RBM5 TNRC6B RAPGEF2 MAP3K6 THRAP3 CNOT2 NXF1 PRRC2B	6.46e-04	775	63	9	int:BTRC
Cytoband	7q11.23	LIMK1 POM121 POM121B	3.31e-04	97	63	3	7q11.23
GeneFamily	LIM domain containing	LIMK1 TRIP6 ZNF185	2.37e-04	59	37	3	1218
GeneFamily	PDZ domain containing	LIMK1 RAPGEF6 RAPGEF2 TIAM2	2.56e-04	152	37	4	1220
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC18 TNRC6B	1.19e-03	25	37	2	775
GeneFamily	Forkhead boxes	FOXD2 FOXO4	3.49e-03	43	37	2	508
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAPT YLPM1 CAMSAP3	5.97e-03	181	37	3	694
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	KALRN TIAM2	8.05e-03	66	37	2	722
Coexpression	GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP	RAPGEF6 BAZ2A RBM5 TNRC6B FOXO4 TRIM24	7.89e-06	200	62	6	M6019
Coexpression	GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP	CABYR BAZ2A TNRC6B TRIM24 AHDC1	4.64e-05	166	62	5	M7722
Coexpression	GENTILE_UV_HIGH_DOSE_DN	POM121 WEE1 RBM5 RAPGEF2 AHDC1 CNOT2	6.25e-05	289	62	6	M13630
Coexpression	GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN	HDAC9 CCP110 WEE1 CDK14 TIAM2	1.02e-04	196	62	5	M4431
Coexpression	GSE22886_TCELL_VS_BCELL_NAIVE_DN	HDAC9 CCP110 COBLL1 CDK14 TIAM2	1.07e-04	198	62	5	M4426
Coexpression	GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP	BAZ2A RBM5 THRAP3 TIAM2 PRRC2B	1.09e-04	199	62	5	M7325
Coexpression	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	RBM5 TNRC6B FYB1 CNOT2 NXF1	1.09e-04	199	62	5	M4460
Coexpression	GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN	ANXA1 COBLL1 CC2D1A TIAM2 DMAC1	1.12e-04	200	62	5	M9290
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN	TLE2 DACH1 POLR1B QSER1 CNOT2	1.12e-04	200	62	5	M3904
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	TNRC18 POM121 ATN1 POM121B PRRC2B	1.34e-04	208	62	5	MM581
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	KIAA1217 COBLL1 DACH1 TNRC6B CDK14	1.34e-04	208	62	5	M39233
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	ATN1 MAPT CAMSAP3 NAV1 TNRC6B PRRC2B	3.94e-07	200	63	6	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	FOXD2 KALRN NCAN DACH1 NAV1 ZIC2	3.94e-07	200	63	6	332905a686356cd1e024d40679be98e9d8b1b5e8
ToppCell	Influenza_Severe-B_memory\|World / Disease group and Cell class	RGSL1 WEE1 COBLL1 MUC16 CDK14	3.38e-06	162	63	5	21eb96cd4fecd85dd6acbbc3760944fa1a7cff42
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CABYR MAP1A KALRN COBLL1 TIAM2	4.40e-06	171	63	5	b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CABYR MAP1A KALRN COBLL1 TIAM2	4.40e-06	171	63	5	9d825a2e799421af4f2cf4f4dc8e239b5d00476d
ToppCell	Control-Endothelial_cells-Endothelial_cells_(other)\|Control / group, cell type (main and fine annotations)	KALRN KIAA1217 SH2D3C DACH1 NAV1	6.62e-06	186	63	5	c6075fe84226b370c5139066793844ad33ae2db1
ToppCell	Control-Endothelial_cells\|Control / group, cell type (main and fine annotations)	KALRN KIAA1217 SH2D3C DACH1 NAV1	6.97e-06	188	63	5	3953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KALRN KIAA1217 SH2D3C DACH1 RAPGEF2	7.16e-06	189	63	5	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KALRN KIAA1217 COBLL1 SH2D3C DACH1	7.34e-06	190	63	5	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KALRN KIAA1217 SH2D3C DACH1 NAV1	7.92e-06	193	63	5	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	HDAC9 WEE1 COBLL1 CDK14 TIAM2	7.92e-06	193	63	5	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	KALRN KIAA1217 SH2D3C DACH1 MAP3K6	7.92e-06	193	63	5	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	RV-09._Endothelium_I\|RV / Chamber and Cluster_Paper	KALRN KIAA1217 SH2D3C DACH1 MAP3K6	8.12e-06	194	63	5	7b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	KALRN KIAA1217 SH2D3C DACH1 MAP3K6	8.33e-06	195	63	5	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	KALRN KIAA1217 SH2D3C DACH1 RAPGEF2	8.33e-06	195	63	5	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	KALRN KIAA1217 SH2D3C DACH1 MAP3K6	8.75e-06	197	63	5	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	HDAC9 MAP1A NCAN AHDC1	4.26e-05	137	63	4	ed81624b9167255ce88dcf6ad7f1636376ea0525
ToppCell	PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	HDAC9 MAP1A NCAN AHDC1	4.26e-05	137	63	4	47859aa25f32367461c1ec75ed9060bee430c6b7
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMK1 RGSL1 MAP1A MAPT	4.39e-05	138	63	4	c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 KALRN SH2D3C DACH1	6.07e-05	150	63	4	4f31867cb85253ff6d22f3b02ef972a42cb41123
ToppCell	COVID-19_Mild\|World / 5 Neutrophil clusters in COVID-19 patients	MAP1A MAPT FOXO4 FYB1	6.39e-05	152	63	4	2ff0980dfd8d430cca14649151d856edef115720
ToppCell	Control-MAIT\|World / Disease group and Cell class	HDAC9 RAPGEF6 TLE2 TIAM2	8.37e-05	163	63	4	0ca4b835936b4f82217cbe57210c1dd90986c1d0
ToppCell	Influenza_Severe-B_memory\|Influenza_Severe / Disease group and Cell class	WEE1 COBLL1 MUC16 CDK14	8.78e-05	165	63	4	51172acaeb667b34b8b8c7878d67cfa0c4a2dffc
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF12 OGDHL PLG FYB1	8.78e-05	165	63	4	34fd00be2b28716c871ad9fb356de84a299a0c01
ToppCell	COVID-19_Mild-PLT_0\|COVID-19_Mild / Disease Group and Platelet Clusters	ATN1 PLG FYB1 DMAC1	8.78e-05	165	63	4	083a14d3b0162cee4e79f7398b8fb739582b39ff
ToppCell	10x5'-Lung-Myeloid_Dendritic-pDC\|Lung / Manually curated celltypes from each tissue	HDAC9 MAP1A COBLL1 DACH1	9.41e-05	168	63	4	90f713dae3fcbd6ca801a019e3861c263ff3366b
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FOXD2 CABYR RAPGEF6 TIAM2	9.63e-05	169	63	4	3f738fc56bbc70dc77c9ba41025631f8264cd2b3
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.01e-04	171	63	4	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	severe_influenza-B_memory\|World / disease group, cell group and cell class (v2)	RGSL1 WEE1 COBLL1 MUC16	1.03e-04	172	63	4	0ff38f9431cec73250c580a6010cb7891a3fe3f1
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGSL1 MAP1A KALRN FYB1	1.05e-04	173	63	4	f0eb48c1283bdde313bb75f6ffc0d2626922d24b
ToppCell	Control-Myeloid-pDC\|World / Disease state, Lineage and Cell class	HDAC9 MAP1A COBLL1 DACH1	1.18e-04	178	63	4	20ef63d925e67ddd5955832312ca8574a6f838a4
ToppCell	3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KALRN ANXA1 OGDHL FYB1	1.20e-04	179	63	4	906555ce2ca264a0215b120c7ff7c9b411de6a34
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	KALRN KIAA1217 SH2D3C DACH1	1.23e-04	180	63	4	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	severe-CD8+_T_naive\|severe / disease stage, cell group and cell class	DNHD1 RGSL1 TRIP6 TRIM24	1.23e-04	180	63	4	94fe530367b170777f4051a4034cff06d80dbb83
ToppCell	severe-CD8+_T_naive\|World / disease stage, cell group and cell class	DNHD1 RGSL1 TRIP6 TRIM24	1.25e-04	181	63	4	69eeeb7f326e230b07495d557f708fbe3312ac0a
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	KALRN KIAA1217 SH2D3C DACH1	1.25e-04	181	63	4	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HDAC9 RBM5 TNRC6B PLG	1.28e-04	182	63	4	ab78df9de3878a6d67106a40094c893601de8076
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.28e-04	182	63	4	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.28e-04	182	63	4	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 WEE1 COBLL1 CDK14	1.31e-04	183	63	4	ffa831f67ed005f05d1b80ebc707e046fc08e22f
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	KALRN SH2D3C NAV1 MAP3K6	1.31e-04	183	63	4	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WEE1 COBLL1 CDK14 TIAM2	1.36e-04	185	63	4	91c9a3ea1afd97d35bd05648875d29b35fe09128
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	KIAA1217 SH2D3C DACH1 NAV1	1.36e-04	185	63	4	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	Control-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	KALRN KIAA1217 COBLL1 SH2D3C	1.36e-04	185	63	4	a28187c2fd23564314b35759479ff2ca21f61485
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CCP110 TNRC18 MAPT TLE2	1.36e-04	185	63	4	daea170d827226dda6750bf1838ffd82f070c4d4
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	XKR7 HOXD1 TLE2 KIAA1217	1.39e-04	186	63	4	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1217 SH2D3C DACH1 TRIM24	1.42e-04	187	63	4	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 KALRN DACH1 MAP3K6	1.42e-04	187	63	4	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KIAA1217 COBLL1 SH2D3C DACH1	1.42e-04	187	63	4	97b2463fb37e7196dd2f92553acf8e7bc3ec40dd
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	KIAA1217 SH2D3C DACH1 NAV1	1.42e-04	187	63	4	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	KALRN KIAA1217 COBLL1 SH2D3C	1.42e-04	187	63	4	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.45e-04	188	63	4	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KALRN KIAA1217 SH2D3C DACH1	1.48e-04	189	63	4	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	IPF-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	KALRN KIAA1217 COBLL1 SH2D3C	1.48e-04	189	63	4	ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f
ToppCell	COVID-19_Severe-Lymphoid_B-B_memory\|COVID-19_Severe / Disease group, lineage and cell class	WEE1 COBLL1 CDK14 TIAM2	1.51e-04	190	63	4	b6510c419a15ed049c0a0a6a6697b643668741c3
ToppCell	IPF-Endothelial-VE_Capillary_A\|IPF / Disease state, Lineage and Cell class	KALRN KIAA1217 COBLL1 SH2D3C	1.51e-04	190	63	4	b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.51e-04	190	63	4	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory\|lymph-node_spleen / Manually curated celltypes from each tissue	HDAC9 WEE1 COBLL1 CDK14	1.54e-04	191	63	4	c3ca8077da8594fb493e47ac4dfbbd20bfc14b37
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.54e-04	191	63	4	f229abf69a1217194f74b0502486907e07dba989
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.57e-04	192	63	4	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	DACH1 TNRC6B RAPGEF2 CDK14	1.57e-04	192	63	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1217 COBLL1 SH2D3C DACH1	1.60e-04	193	63	4	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KIAA1217 SH2D3C DACH1 NAV1	1.60e-04	193	63	4	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 KALRN SH2D3C NAV1	1.60e-04	193	63	4	287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1217 SH2D3C DACH1 NAV1	1.64e-04	194	63	4	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1217 SH2D3C DACH1 NAV1	1.64e-04	194	63	4	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1217 SH2D3C DACH1 NAV1	1.64e-04	194	63	4	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1217 SH2D3C DACH1 NAV1	1.64e-04	194	63	4	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NCAN MUC16 OGDHL FOXO4	1.64e-04	194	63	4	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	Adult-Endothelial\|Adult / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.64e-04	194	63	4	963b3fbee0575af8379baa397ace65949eaf34f7
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	KALRN KIAA1217 SH2D3C DACH1	1.67e-04	195	63	4	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.67e-04	195	63	4	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KALRN KIAA1217 SH2D3C DACH1	1.70e-04	196	63	4	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KALRN KIAA1217 SH2D3C DACH1	1.70e-04	196	63	4	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	severe_COVID-19-B_memory\|severe_COVID-19 / disease group, cell group and cell class (v2)	WEE1 COBLL1 CDK14 TIAM2	1.70e-04	196	63	4	c6e00cb59a88b9903cca233cefe05f80c5ea4153
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KIAA1217 SH2D3C DACH1 NAV1	1.70e-04	196	63	4	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	KALRN KIAA1217 SH2D3C DACH1	1.70e-04	196	63	4	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	KALRN KIAA1217 SH2D3C DACH1	1.70e-04	196	63	4	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	TRIP6 WEE1 ANXA1 DACH1	1.74e-04	197	63	4	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	MAP1A KALRN MAPT SH2D3C	1.74e-04	197	63	4	c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	KIAA1217 SH2D3C DACH1 NAV1	1.74e-04	197	63	4	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KALRN KIAA1217 SH2D3C DACH1	1.74e-04	197	63	4	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA1217 SH2D3C DACH1 NAV1	1.74e-04	197	63	4	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANXA1 KIAA1217 ZNF185 MUC16	1.74e-04	197	63	4	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	KALRN KIAA1217 SH2D3C DACH1	1.74e-04	197	63	4	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	TRIP6 WEE1 ANXA1 DACH1	1.74e-04	197	63	4	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN KIAA1217 SH2D3C DACH1	1.77e-04	198	63	4	a1ccbf0e653b2dd665c2254920eb9b37243cc0bd
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA1217 SH2D3C DACH1 NAV1	1.77e-04	198	63	4	1d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	KIAA1217 SH2D3C DACH1 NAV1	1.80e-04	199	63	4	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Bronchial-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN KIAA1217 SH2D3C DACH1	1.80e-04	199	63	4	36a230b80096455df26c2e2c8c05fd6b231508c5
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN SH2D3C DACH1 NAV1	1.80e-04	199	63	4	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN SH2D3C DACH1 NAV1	1.80e-04	199	63	4	d58edc5f74970bb26d844746184e4bae7c494d6b
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 KALRN SH2D3C DACH1	1.80e-04	199	63	4	e2d5c5cab102e67b0131b02392d81adaedc15965
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN SH2D3C DACH1 NAV1	1.80e-04	199	63	4	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-B_memory\|COVID-19_Severe / Disease, condition lineage and cell class	WEE1 COBLL1 CDK14 TIAM2	1.80e-04	199	63	4	24c05faa825c9d55279956469862440f9914a280
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	TRIP6 ANXA1 NCAN DACH1	1.80e-04	199	63	4	151bda6821b52cfb4491474892ecb45781522837
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	WEE1 DACH1 NAV1 TRIM24	1.80e-04	199	63	4	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN KIAA1217 SH2D3C DACH1	1.84e-04	200	63	4	105c67e4f5eff036013d655c8e8ac577d32dae2e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	KALRN PRRC2B ZIC2	2.91e-04	91	63	3	25197fde8b9bdaf1e28add695d13aff3ff52d86e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related-Oligodendrocyte/OPC\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	KALRN PRRC2B ZIC2	2.91e-04	91	63	3	ed4a48e5e5f5d8aadbc7b1b8d84a5f6363a08b85
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	GPALPP1 KIAA0232 RBM5 RAPGEF2 TRIM24 CNOT2	8.41e-06	182	60	6	3887_DN
Drug	Apigenin [520-36-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A	HDAC9 KALRN FBXO42 CC2D1A CDK14 FYB1	1.21e-05	194	60	6	4401_UP
Drug	ST021200; Up 200; 10uM; PC3; HT_HG-U133A	BAZ2A FBXO42 YLPM1 POLR1B CC2D1A PRRC2B	1.25e-05	195	60	6	7559_UP
Drug	Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A	HIPK3 BAZ2A RBM5 FOXO4 CDK14 FYB1	1.25e-05	195	60	6	4969_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	HIPK3 ATN1 RBM5 QSER1 RAPGEF2 AHDC1	1.28e-05	196	60	6	990_UP
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	CABYR BAZ2A YLPM1 DACH1 POLR1B RAPGEF2	1.28e-05	196	60	6	1629_DN
Drug	rotenone; Down 200; 1uM; PC3; HT_HG-U133A	HIPK3 ATN1 HOXD1 MAPT OGDHL CDK14	1.32e-05	197	60	6	5948_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	HIPK3 LIMK1 ATN1 BAZ2A TLE2 CC2D1A	1.32e-05	197	60	6	5592_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	LIMK1 ATN1 HOXD1 TLE2 YLPM1 DACH1	1.36e-05	198	60	6	4762_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	BAZ2A FBXO42 YLPM1 CC2D1A AHDC1 PRRC2B	1.36e-05	198	60	6	7180_DN
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	HIPK3 MAP1A ANXA1 FOXO4 QSER1	1.04e-04	177	60	5	2678_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	HDAC9 WEE1 TNRC6B CC2D1A CDK14	1.41e-04	189	60	5	1206_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A	CABYR MAP1A MAPT COBLL1 NCAN	1.56e-04	193	60	5	5600_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A	HIPK3 LIMK1 HOXD1 WEE1 QSER1	1.56e-04	193	60	5	4443_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	ATN1 BAZ2A MAPT FYB1 PRRC2B	1.56e-04	193	60	5	4186_DN
Drug	Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	LIMK1 BAZ2A TLE2 YLPM1 AHDC1	1.59e-04	194	60	5	5755_DN
Drug	SC 19220; Up 200; 10uM; PC3; HT_HG-U133A	BAZ2A TLE2 COBLL1 RBM5 FYB1	1.59e-04	194	60	5	7065_UP
Drug	Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	MAP1A BAZ2A MAPT TNRC6B FYB1	1.59e-04	194	60	5	4470_DN
Drug	Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A	HIPK3 LIMK1 ATN1 MAPT FYB1	1.59e-04	194	60	5	7413_UP
Drug	0393-0188; Up 200; 10uM; MCF7; HT_HG-U133A	HIPK3 LIMK1 MAPT TLE2 RBM5	1.63e-04	195	60	5	7531_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A	HIPK3 LIMK1 BAZ2A MAPT COBLL1	1.63e-04	195	60	5	3732_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; PC3; HT_HG-U133A	CABYR LIMK1 CC2D1A QSER1 FYB1	1.63e-04	195	60	5	3984_DN
Drug	Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A	HOXD1 BAZ2A MAPT RAPGEF2 MAP3K6	1.67e-04	196	60	5	3263_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; PC3; HT_HG-U133A	CCP110 BAZ2A COBLL1 YLPM1 QSER1	1.67e-04	196	60	5	6637_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; PC3; HT_HG-U133A	ATN1 BAZ2A MAPT TLE2 FOXO4	1.67e-04	196	60	5	4564_UP
Drug	DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A	ATN1 BAZ2A WEE1 COBLL1 DACH1	1.67e-04	196	60	5	7513_DN
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	HIPK3 FBXO42 CC2D1A QSER1 FYB1	1.67e-04	196	60	5	6273_UP
Drug	AH6809; Up 200; 1uM; PC3; HT_HG-U133A	LIMK1 MAP1A KALRN BAZ2A FYB1	1.71e-04	197	60	5	7049_UP
Drug	Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	CABYR ATN1 MAPT TNRC6B FYB1	1.71e-04	197	60	5	4183_DN
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	HIPK3 ATN1 BAZ2A TLE2 CC2D1A	1.71e-04	197	60	5	5703_UP
Drug	Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A	LIMK1 KIAA0232 OGDHL RAPGEF2 AHDC1	1.71e-04	197	60	5	1503_UP
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	LIMK1 BAZ2A CC2D1A MAP3K6 AHDC1	1.71e-04	197	60	5	4532_DN
Drug	PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A	ATN1 MAPT TLE2 CDK14 FYB1	1.71e-04	197	60	5	5939_UP
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	ATN1 MAP1A TLE2 COBLL1 CDK14	1.71e-04	197	60	5	5633_UP
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	BAZ2A MAPT RBM5 RAPGEF2 FYB1	1.71e-04	197	60	5	2860_UP
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	LIMK1 MAPT TLE2 RBM5 CDK14	1.71e-04	197	60	5	7533_UP
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A	GPALPP1 LIMK1 ATN1 BAZ2A TLE2	1.71e-04	197	60	5	4613_DN
Drug	Norethindrone [68-22-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	HIPK3 LIMK1 ATN1 MAPT MAP3K6	1.71e-04	197	60	5	5055_DN
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	LIMK1 ATN1 MAP1A MAPT YLPM1	1.71e-04	197	60	5	4295_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	LIMK1 TLE2 DACH1 QSER1 RAPGEF2	1.71e-04	197	60	5	4745_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; HL60; HG-U133A	ATN1 HOXD1 FBXO42 YLPM1 TNRC6B	1.71e-04	197	60	5	1388_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A	GPALPP1 CABYR FBXO42 YLPM1 PRRC2B	1.71e-04	197	60	5	1215_DN
Drug	Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A	BAZ2A WEE1 COBLL1 CC2D1A AHDC1	1.75e-04	198	60	5	7166_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	HIPK3 HOXD1 BAZ2A DACH1 FYB1	1.75e-04	198	60	5	6023_DN
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	MAPT ANXA1 COBLL1 FBXO42 POLR1B	1.75e-04	198	60	5	1633_DN
Drug	Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A	HIPK3 LIMK1 ATN1 MAP1A CC2D1A	1.75e-04	198	60	5	5064_DN
Drug	Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	MAPT TLE2 FBXO42 RBM5 QSER1	1.75e-04	198	60	5	5786_DN
Drug	Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HG-U133A	CCP110 YLPM1 CC2D1A RAPGEF2 PRRC2B	1.75e-04	198	60	5	1900_DN
Drug	Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	FOXD2 HOXD1 COBLL1 CC2D1A FOXO4	1.75e-04	198	60	5	4608_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A	LIMK1 ATN1 BAZ2A OGDHL PRRC2B	1.75e-04	198	60	5	3756_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	BAZ2A MAPT WEE1 COBLL1 MAP3K6	1.75e-04	198	60	5	3424_DN
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; PC3; HT_HG-U133A	HDAC9 MAPT YLPM1 RAPGEF2 AHDC1	1.79e-04	199	60	5	5875_DN
Drug	Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A	FOXD2 NCAN ZNF185 YLPM1 MAP3K6	1.79e-04	199	60	5	2469_UP
Drug	haloperidol; Up 200; 10uM; HL60; HT_HG-U133A	HIPK3 ATN1 HOXD1 BAZ2A QSER1	1.79e-04	199	60	5	2663_UP
Drug	Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; HL60; HT_HG-U133A	LIMK1 COBLL1 CC2D1A FOXO4 FYB1	1.79e-04	199	60	5	2376_UP
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	GPALPP1 BAZ2A COBLL1 FBXO42 YLPM1	1.79e-04	199	60	5	1210_DN
Drug	Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; PC3; HT_HG-U133A	CABYR LIMK1 MAPT COBLL1 RBM5	1.84e-04	200	60	5	4014_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A	HDAC9 WEE1 YLPM1 RAPGEF2 PRRC2B	1.84e-04	200	60	5	1376_DN
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; PC3; HG-U133A	HOXD1 TRIP6 WEE1 KIAA0232 YLPM1	1.84e-04	200	60	5	1939_UP
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	BAZ2A TNRC6B POLR1B CC2D1A AHDC1	1.84e-04	200	60	5	7182_DN
Drug	Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A	HDAC9 LIMK1 BAZ2A FOXO4 CDK14	1.84e-04	200	60	5	2272_UP
Disease	coronary atherosclerosis measurement	HDAC9 NAV1	4.33e-05	5	62	2	EFO_0007938
Disease	abdominal aortic artery calcification	HDAC9 NAV1	9.06e-05	7	62	2	EFO_0004859
Disease	cholesteryl esters to total lipids in small LDL percentage	COBLL1 NCAN PLG	9.57e-05	42	62	3	EFO_0022255
Disease	aortic measurement	HDAC9 LIMK1 KALRN NAV1 TNRC6B	1.87e-04	251	62	5	EFO_0020865
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A NCAN	1.93e-04	10	62	2	EFO_0004530, EFO_0600007
Disease	dry eye syndrome (is_marker_for)	ANXA1 MUC16	1.93e-04	10	62	2	DOID:10140 (is_marker_for)
Disease	androstenedione measurement, estrone measurement	CDK14 DMAC1	6.50e-04	18	62	2	EFO_0007970, EFO_0007972
Disease	Osteoarthritis of hip	HDAC9 MAPT	8.05e-04	20	62	2	C0029410
Disease	platelet crit	HDAC9 MAP1A KALRN NCAN YLPM1 DACH1 POLR1B FYB1	8.25e-04	952	62	8	EFO_0007985
Disease	platelet component distribution width	HDAC9 KALRN BAZ2A WEE1 KIAA0232 COBLL1 FYB1	1.01e-03	755	62	7	EFO_0007984
Disease	total brain volume change measurement, age at assessment	COBLL1 DACH1	1.26e-03	25	62	2	EFO_0008007, EFO_0021504
Disease	triacylglycerol 52:6 measurement	NCAN DACH1	1.26e-03	25	62	2	EFO_0010418
Disease	spontaneous preterm birth	HDAC9 KALRN KIAA1217	1.27e-03	101	62	3	EFO_0006917
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	MAP1A COBLL1 NCAN PLG	1.28e-03	224	62	4	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	COBLL1 NCAN PLG	1.62e-03	110	62	3	EFO_0008317, EFO_0008596, EFO_0010351
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	COBLL1 NCAN PLG	1.62e-03	110	62	3	EFO_0004574, EFO_0008317, EFO_0008596
Disease	alopecia	FOXD2 HDAC9 HOXD1 MAPT	1.67e-03	241	62	4	MONDO_0004907
Disease	neutrophil percentage of leukocytes	HDAC9 KALRN MAPT COBLL1 SH2D3C TNRC6B	1.76e-03	610	62	6	EFO_0007990
Disease	immature platelet fraction	KALRN BAZ2A KIAA0232	1.80e-03	114	62	3	EFO_0009187
Disease	immature platelet measurement	KALRN BAZ2A KIAA0232	2.03e-03	119	62	3	EFO_0803541
Disease	Unipolar Depression	HDAC9 KALRN CC2D1A PLG	2.17e-03	259	62	4	C0041696
Disease	pulse pressure measurement	HDAC9 LIMK1 KIAA1217 COBLL1 NAV1 TNRC6B CDK14 AHDC1 DMAC1	2.40e-03	1392	62	9	EFO_0005763
Disease	brain ischemia (implicated_via_orthology)	MAPT ANXA1	2.47e-03	35	62	2	DOID:2316 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in medium LDL percentage	COBLL1 PLG	2.76e-03	37	62	2	EFO_0022252
Disease	androgenetic alopecia	FOXD2 HDAC9 MAPT	2.79e-03	133	62	3	EFO_0004191
Disease	very low density lipoprotein particle size measurement	COBLL1 NCAN PLG	2.79e-03	133	62	3	EFO_0008594
Disease	oral microbiome measurement	HDAC9 KIAA1217	3.54e-03	42	62	2	EFO_0801229
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement	COBLL1 DMAC1	3.71e-03	43	62	2	EFO_0007788, EFO_0008343
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	COBLL1 NCAN PLG	4.13e-03	153	62	3	EFO_0004611, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	COBLL1 NCAN PLG	4.13e-03	153	62	3	EFO_0004611, EFO_0020944

Protein segments in the cluster

Peptide	Gene	Start	Entry
PFLGSGATSYSKPPG	ERFL	201	A0A1W2PQ73
SYITAPPGTAAAPAK	DMAC1	11	Q96GE9
SGLKPSPSSGEGLYT	BAZ2A	21	Q9UIF9
VASSPAGYKTASPPG	ATN1	621	P54259
SGTSVKSSSGPFPPA	CABYR	461	O75952
PSSPTSPKFGKADSY	CDK14	121	O94921
YLSLSSTVLGPAPGP	DNHD1	4016	Q96M86
KASGTYAGPPTSALP	AHDC1	866	Q5TGY3
SSSCGPLPGKPVYST	DACH1	161	Q9UI36
GSFYLHSPEGPSKPS	CAMSAP3	481	Q9P1Y5
LKTFGAPRPYSSSGP	COBLL1	971	Q53SF7
SAIPSSGYPPSTTKI	QSER1	266	Q2KHR3
KSSKGGPGSAVSPYP	ANXA1	26	P04083
ASGSYPSPKAGATLV	FBXO42	166	Q6P3S6
PAAYSGSPKISSSPN	MUC16	1361	Q8WXI7
STPSGNGKYLPGAIT	MAP1A	1296	P78559
GPSAASETPKSLPYA	MAGEL2	806	Q9UJ55
GTYPKSVSPASGLPA	HOXD1	186	Q9GZZ0
TGSGKTYTLTGPPPQ	KIF12	106	Q96FN5
PSPPKRCLSYGGTSQ	MAP3K6	956	O95382
PASVSSYAGGVPPTL	FOXO4	286	P98177
GLPSESSSSSYPGPV	KIAA0232	11	Q92628
APTTLPPCKGSYFGT	NXF1	366	Q9UBU9
SRSSGPPATFPSSKG	OGDHL	31	Q9ULD0
SKGQTSYSTTSLPPP	FYB1	381	O15117
YSSVPAGSEKPPKGS	KALRN	2266	O60229
SPAYTGFPLSPTKLS	HIPK3	1196	Q9H422
PAASPTGVVPGTKYA	RBM5	441	P52756
FGSSAKSPLPSYPGA	POM121B	536	A6NF01
PFGSSAKSPLPSYPG	POM121	951	Q96HA1
AGPALPPNYKSSSSD	GPALPP1	31	Q8IXQ4
AIGKGPASTPTYSPA	CC2D1A	196	Q6P1N0
SLTGSYAKLPSPEPS	CCP110	356	O43303
DQSSPPLSGTSPSYK	HDAC9	186	Q9UKV0
PLSGTSPSYKYTLPG	HDAC9	191	Q9UKV0
SGGAATRSPLVKPPY	FOXD2	116	O60548
KPPSGIARPSTSGSF	NAV1	591	Q8NEY1
TSGSFGYKKPPPATG	NAV1	601	Q8NEY1
SPPKSTDKYPFSSGG	RGSL1	1001	A5PLK6
SPQGSPHKGYTLIPS	RAPGEF6	1241	Q8TEU7
YSKGLDASSPSAPLG	NCAN	786	O14594
SGGDFKPTSPSLPAS	KIAA1217	1786	Q5T5P2
PPSSGPTYQCLKGTG	PLG	266	P00747
PALPGSSYKDPTSSN	CNOT2	281	Q9NZN8
PQSSPRKGYTLAPSG	RAPGEF2	1121	Q9Y4G8
KSLLSLGSYPPAAGS	TNRC18	2496	O15417
LGSYPPAAGSSEPKA	TNRC18	2501	O15417
LSSPVGGSYNLPSLP	TRIM24	611	O15164
GPTPASYTTASTPAG	TRIP6	151	Q15654
SSSPVKSPAAPYFLG	WEE1	121	P30291
PVGKSPPSTGSTYGS	THRAP3	316	Q9Y2W1
PGSPTPGPFSYTKAS	nan	61	Q6ZUT4
SGSGALPPYAPKLSS	ZC3H6	1016	P61129
YSEPAGSPGPAVSTK	XKR7	116	Q5GH72
SKSTSPGKYPHPGLA	TIAM2	1541	Q8IVF5
TYRPSSASPSGKPSG	PRRC2B	2156	Q5JSZ5
PKSGDRSGYSSPGSP	MAPT	506	P10636
ALPEASPGPGYSSST	YLPM1	26	P49750
GKASPSPSLSSYSDP	SH2D3C	476	Q8N5H7
GSLIYGFPPSSFSSP	TRIM64C	426	A6NLI5
PSGPSLKHLTDPSYG	POLR1B	11	Q9H9Y6
SSSLPSIPGGKPAYS	TLE2	406	Q04725
TANAGPPRPSSSGYK	ZNF185	121	O15231
SPFSPSPSYKLSPSG	TNRC6B	1156	Q9UPQ9
SPSYKLSPSGSTLPN	TNRC6B	1161	Q9UPQ9
PAASSGYESSTPPGL	ZIC2	426	O95409
GYESSTPPGLVSPSA	ZIC2	431	O95409
SPLSSPAYTPSGEAG	LIMK1	271	P53667
SPPASPSGSYITADG	NACAD	211	O15069